- 全部删除
您的购物车当前为空
GLPG3970 是一种新型可口服具有选择性的 SIK2/SIK3 双重抑制剂。GLPG3970 具有潜在的抗炎活性,可用于研究自身免疫性疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
GLPG3970 是一种新型可口服具有选择性的 SIK2/SIK3 双重抑制剂。GLPG3970 具有潜在的抗炎活性,可用于研究自身免疫性疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 413 | In stock | |
| 5 mg | ¥ 818 | In stock | |
| 10 mg | ¥ 1,230 | In stock | |
| 25 mg | ¥ 2,460 | In stock | |
| 50 mg | ¥ 3,690 | In stock | |
| 100 mg | ¥ 5,260 | In stock | |
| 200 mg | ¥ 7,190 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 891 | In stock |
GLPG3970 相关产品
| 产品描述 | GLPG3970 GLPG3970 is a novel orally available selective dual SIK2/SIK3 inhibitor.GLPG3970 has potential anti-inflammatory activity for the study of autoimmune diseases. |
| 靶点活性 | SIK2:7.8 nM, SIK1:282.8 nM, SIK3:3.8 nM |
| 分子量 | 504.5 |
| 分子式 | C25H27F3N4O4 |
| CAS No. | 2403733-82-2 |
| Smiles | O=C1C=2C(OC)=CC(=CC2CCN1CC(F)(F)F)C3=CN=C4C=C(OCCN5CCOCC5)C=CN43 |
| 存储 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 128.8 mg/mL (255.3 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (6.54 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容